https://doi.org/10.1016/j.apsb.2025.06.005

This new article publication from Acta Pharmaceutica Sinica B, discusses how the protein arginine methyltransferase PRMT1 ameliorates cerebral ischemia–reperfusion injury by suppressing RIPK1-mediated necroptosis and apoptosis.

https://doi.org/10.1016/j.apsb.2025.05.031

This new article publication from Acta Pharmaceutica Sinica B, discusses how a novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A.

https://doi.org/10.1016/j.apsb.2025.05.025

This new article publication from Acta Pharmaceutica Sinica B, discusses the efficacy of targeting the Keap1 system through the homoPROTAC-ing technology as an innovative and promising treatment strategy for the incurable allergic disorders.

https://doi.org/10.1016/j.apsb.2025.06.004

This new article publication from Acta Pharmaceutica Sinica B, discusses an efficient strategy for discovering anti-Notum compounds from herbal medicines.

https://doi.org/10.1016/j.apsb.2025.06.001

This new article publication from Acta Pharmaceutica Sinica B, discusses an AI-integrated quality prediction and diagnostics framework that could transform small-sample pharmaceutical manufacturing from experience-driven practices to data-driven precision.

MIT physicists introduce a concept for a “neutrino laser” — a burst of neutrinos that could be produced by laser-cooling a gas of radioactive atoms down to temperatures colder than interstellar space. Such a laser could be used as a new form of communication or a new source of radioisotopes in medicine.